Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benedetti, M. D.
Right arrow Articles by Rocca, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benedetti, M. D.
Right arrow Articles by Rocca, W. A.
Neurology 2000;55:1350-1358
© 2000 American Academy of Neurology


Articles

Smoking, alcohol, and coffee consumption preceding Parkinson’s disease

A case-control study M. D. Benedetti, MD, MSc, J. H. Bower, MD, D. M. Maraganore, MD, S. K. McDonnell, MS, B. J. Peterson, BS, J. E. Ahlskog, PhD, MD, D. J. Schaid, PhD and W. A. Rocca, MD, MPH

From the Departments of Health Sciences Research (Drs. Benedetti, Schaid, and Rocca, S.K. McDonnell, and B.J. Peterson) and Neurology (Drs. Maraganore, Bower, Ahlskog, and Rocca), Mayo Clinic and Mayo Foundation, Rochester, MN.

Address correspondence and reprint requests to Dr. W.A. Rocca, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

OBJECTIVE: To study the association of PD with preceding smoking, alcohol, and coffee consumption using a case-control design.

METHODS: The authors used the medical records linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, MN, during the years 1976 to 1995. Each incident case was matched by age (±1 year) and sex to a general population control subject. The authors reviewed the complete medical records of cases and control subjects to abstract exposure information.

RESULTS: For coffee consumption, the authors found an OR of 0.35 (95% CI = 0.16 to 0.78, p = 0.01), a dose–effect trend (p = 0.003), and a later age at PD onset in cases who drank coffee compared with those who never did (median 72 versus 64 years; p = 0.0002). The inverse association with coffee remained significant after adjustment for education, smoking, and alcohol drinking and was restricted to PD cases with onset at age <72 years and to men. The OR for cigarette smoking was 0.69 (95% CI = 0.45 to 1.08, p = 0.1). The authors found no association between PD and alcohol consumption. Extreme or unusual behaviors such as tobacco chewing or snuff use and a diagnosis of alcoholism were significantly more common in control subjects than cases.

CONCLUSIONS: These findings suggest an inverse association between coffee drinking and PD; however, this association does not imply that coffee has a direct protective effect against PD. Alternative explanations for the association should be considered.




This article has been cited by other articles:


Home page
NeurologyHome page
R. Savica, J. M. Carlin, B. R. Grossardt, J. H. Bower, J. E. Ahlskog, D. M. Maraganore, A. E. Bharucha, and W. A. Rocca
Medical records documentation of constipation preceding Parkinson disease: A case-control study
Neurology, November 24, 2009; 73(21): 1752 - 1758.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Frigerio, H. Fujishiro, D. M. Maraganore, K. J. Klos, A. DelleDonne, M. G. Heckman, J. E. Crook, K. A. Josephs, J. E. Parisi, B. F. Boeve, et al.
Comparison of Risk Factor Profiles in Incidental Lewy Body Disease and Parkinson Disease
Arch Neurol, September 1, 2009; 66(9): 1114 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. J. O'Reilly, H. Chen, H. Gardener, X. Gao, M. A. Schwarzschild, and A. Ascherio
Smoking and Parkinson's Disease: Using Parental Smoking as a Proxy to Explore Causality
Am. J. Epidemiol., March 15, 2009; 169(6): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. S. Jones, J. Jing, A. H. Stonehouse, A. Stevens, and G. M. Edelman
Caffeine Stimulates Cytochrome Oxidase Expression and Activity in the Striatum in a Sexually Dimorphic Manner
Mol. Pharmacol., September 1, 2008; 74(3): 673 - 684.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
F D Dick, G De Palma, A Ahmadi, N W Scott, G J Prescott, J Bennett, S Semple, S Dick, C Counsell, P Mozzoni, et al.
Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study
Occup. Environ. Med., October 1, 2007; 64(10): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. Ritz, A. Ascherio, H. Checkoway, K. S. Marder, L. M. Nelson, W. A. Rocca, G. W. Ross, D. Strickland, S. K. Van Den Eeden, and J. Gorell
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Arch Neurol, July 1, 2007; 64(7): 990 - 997.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. L. Thacker, E. J. O'Reilly, M. G. Weisskopf, H. Chen, M. A. Schwarzschild, M. L. McCullough, E. E. Calle, M. J. Thun, and A. Ascherio
Temporal relationship between cigarette smoking and risk of Parkinson disease
Neurology, March 6, 2007; 68(10): 764 - 768.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Xu, Y. Xu, D. Brown-Jermyn, J.-F. Chen, A. Ascherio, D. E. Dluzen, and M. A. Schwarzschild
Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
J. Neurosci., January 11, 2006; 26(2): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Frigerio, A. Elbaz, K. R. Sanft, B. J. Peterson, J. H. Bower, J. E. Ahlskog, B. R. Grossardt, M. de Andrade, D. M. Maraganore, and W. A. Rocca
Education and occupations preceding Parkinson disease: A population-based case-control study
Neurology, November 22, 2005; 65(10): 1575 - 1583.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
A.C. Williams, L.S. Cartwright, and D.B. Ramsden
Parkinson's disease: the first common neurological disease due to auto-intoxication?
QJM, March 1, 2005; 98(3): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, and A. Ascherio
Physical activity and the risk of Parkinson disease
Neurology, February 22, 2005; 64(4): 664 - 669.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. K. Scott, F. Zhang, J. M. Stajich, B. L. Scott, M. A. Stacy, and J. M. Vance
Family-based case-control study of cigarette smoking and Parkinson disease
Neurology, February 8, 2005; 64(3): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Ascherio, M. G. Weisskopf, E. J. O'Reilly, M. L. McCullough, E. E. Calle, C. Rodriguez, and M. J. Thun
Coffee Consumption, Gender, and Parkinson's Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen
Am. J. Epidemiol., November 15, 2004; 160(10): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Ascherio and H. Chen
Caffeinated clues from epidemiology of Parkinson's disease
Neurology, December 9, 2003; 61(90116): S51 - 54.
[Full Text]


Home page
NeurologyHome page
A. Ascherio, H. Chen, M.A. Schwarzschild, S.M. Zhang, G.A. Colditz, and F.E. Speizer
Caffeine, postmenopausal estrogen, and risk of Parkinson's disease
Neurology, March 11, 2003; 60(5): 790 - 795.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
F.-M. Zhou, C. Wilson, and J. A. Dani
Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems
Neuroscientist, February 1, 2003; 9(1): 23 - 36.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. Elbaz, J. H. Bower, B. J. Peterson, D. M. Maraganore, S. K. McDonnell, J. E. Ahlskog, D. J. Schaid, and W. A. Rocca
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Arch Neurol, January 1, 2003; 60(1): 91 - 96.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Schwarzschild, J.-F. Chen, and A. Ascherio
Caffeinated clues and the promise of adenosine A2A antagonists in PD
Neurology, April 23, 2002; 58(8): 1154 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. Checkoway, K. Powers, T. Smith-Weller, G. M. Franklin, W. T. Longstreth Jr., and P. D. Swanson
Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake
Am. J. Epidemiol., April 15, 2002; 155(8): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. M. Tanner, S. M. Goldman, D. A. Aston, R. Ottman, J. Ellenberg, R. Mayeux, and J. W. Langston
Smoking and Parkinson's disease in twins
Neurology, February 26, 2002; 58(4): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Deleu, W. A. Rocca, D. M. Maraganore, and M. D. Benedetti
Smoking, alcohol, and coffee consumption preceding Parkinson's disease
Neurology, April 10, 2001; 56(7): 984 - 985.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-F. Chen, K. Xu, J. P. Petzer, R. Staal, Y.-H. Xu, M. Beilstein, P. K. Sonsalla, K. Castagnoli, N. Castagnoli Jr, and M. A. Schwarzschild
Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease
J. Neurosci., May 15, 2001; 21(10): RC143 - RC143.
[Abstract] [Full Text] [PDF]